1. Home
  2. News
  3. InventisBio, Co., Ltd.
  4. Announcement on Convening the Q3 2025 Performance Briefing
More InventisBio, Co., Ltd. news
InventisBio, Co., Ltd.SSE: 688382

Announcement on Convening the Q3 2025 Performance Briefing

Oct 29, 2025 · Issued by InventisBio, Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 29, 2025 · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-878

InventisBio, Co., Ltd. on 6ix

Earlier from InventisBio

  • Announcement on Progress in LitigationSep 30, 2025
  • Announcement on Vesting Results and Share Listing in the 2nd Vesting Period of Reserved Grant in 2022 Restricted Stock Incentive PlanSep 23, 2025
  • Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Sep 9, 2025
  • Announcement on Changing Some Investment Projects Financed by Raised FundsAug 23, 2025
  • Announcement on Convening the 2025 Semi-annual Performance BriefingAug 19, 2025

Later from InventisBio

  • Report for Q3 2025Oct 30, 2025
  • Announcement on Resolutions of the 8th Meeting of the 2nd Board of Directors in 2025Dec 10, 2025
  • Announcement on Abstract of 2025 Restricted Stock Incentive Plan (Draft)Dec 20, 2025
  • Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Dec 26, 2025
  • Publicity Explanation and Verification Opinions of Remuneration and Appraisal Committee of Board of Directors on List of Incentive Objects in 2025 Restricted Stock Incentive PlanJan 8
All InventisBio news releases↗

Follow InventisBio into a list and get an email when it puts out news.

Follow InventisBio
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer